Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
1998-09-21
2002-10-08
Venkat, Jyothsna (Department: 1627)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100, C435S007230, C435S007600, C435S091500, C435S091500, C435S091500
Reexamination Certificate
active
06461813
ABSTRACT:
FIELD OF THE INVENTION
The invention relates to novel methods of detecting alterations in cell cycle regulation in a cell or a cell population and screening for agents capable of modulating cell cycle regulation through the use of multiparameter assays and a fluorescence-activated cell sorter (FACS) machine.
BACKGROUND OF THE INVENTION
Cells cycle through various stages of growth, starting with the M phase, where mitosis and cytoplasmic division (cytokinesis) occurs. The M phase is followed by the G1 phase, in which the cells resume a high rate of biosynthesis and growth. The S phase begins with DNA synthesis, and ends when the DNA content of the nucleus has doubled. The cell then enters G2 phase, which ends when mitosis starts, signaled by the appearance of condensed chromosomes. Terminally differentiated cells are arrested in the G1 phase, and no longer undergo cell division.
The hallmark of a malignant cell is uncontrolled proliferation. This phenotype is acquired through the accumulation of gene mutations, the majority of which promote passage through the cell cycle. Cancer cells ignore growth regulatory signals and remain committed to cell division. Classic oncogenes, such as ras, lead to inappropriate transition from G1 to S phase of the cell cycle, mimicking proliferative extracellular signals. Cell cycle checkpoint controls ensure faithful replication and segregation of the genome. The loss of cell cycle checkpoint control results in genomic instability, greatly accelerating the accumulation of mutations which drive malignant transformation. Hence, checkpoint regulators, such as p53 and ATM (ataxia telangiectasia mutated), also function as tumor suppressors. Thus, modulating cell cycle checkpoint pathways with therapeutic agents could exploit the differences between normal and tumor cells, both improving the selectivity of radio- and chemotherapy, and leading to novel cancer treatments.
Accordingly, it is an object of the invention to provide compositions and methods useful in screening for modulators of cell cycle checkpoint regulation.
SUMMARY OF THE INVENTION
In accordance with the objects outlined above, the present invention provides methods for screening for a bioactive agent capable of modulating cell cycle regulation in a cell. The method comprises combining a library of candidate bioactive agents and a population of cells, sorting the cells in a FACS machine by separating the cells on the basis of at least a cell viability assay, a proliferation assay, and a cell phase assay.
In a further aspect, the methods comprise expressing a library of fusion nucleic acids in a library of cells. The fusion nucleic acids comprise a nucleic acid encoding a candidate bioactive agent and a detectable moiety. The cells are sorted in a FACS machine by separating the cells on the basis of at least a cell viability assay, an expression assay, a proliferation assay, and a cell phase assay.
REFERENCES:
patent: 4304720 (1981-12-01), Dean et al.
patent: 4816395 (1989-03-01), Hancock et al.
patent: 5552290 (1996-09-01), Michelson et al.
patent: 5645988 (1997-07-01), Vande Woude et al.
patent: 0 415 695 (1991-03-01), None
patent: 0 469 632 (1992-02-01), None
patent: 91/02085 (1991-02-01), None
patent: 9319167 (1993-09-01), None
patent: 9503431 (1995-02-01), None
patent: 9727212 (1997-07-01), None
patent: 98/58085 (1998-12-01), None
Cayrol et al, Oncogene (1998) 16, 311-320.*
Nakanishi et al, The EMBO Journal, 14(3), pp. 555-563, (1995).*
Luo et al, Nature, 375, pp. 159-161, (May 11, 1995).*
Williams et al, Journal of Immunological Methods, 213, 1-17, (1998).*
Clontech, pp. 90-99.*
Polyak et al, Genes & Development, 10, pp. 1945-1952, (1996).*
Tournier et al, Molecular Biology of Cell, 7, 651-662, (Apr. 1996).*
Beuth et al., “Determination of lectin-dependent alterations of cellular parameters by immunophenotyping during adjuvant lectin application,” inLectins and Glycobiology, Gabius and Gabius (eds.). Springer-Verlag, Berlin Heidelberg (1993), pp. 396-401.
Xu, X., et al., “Detection of Programmed Cell Death Using Fluorescence Energy Transfer,”Nucleic Acids Research, 26(8):2034-2035 (1998).
Dorsey & Whitney LLP
Friend Tomas
Rigel Pharmaceuticals Inc.
Silva, Esq. Robin M.
Venkat Jyothsna
LandOfFree
Multiparameter FACS assays to detect alterations in cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multiparameter FACS assays to detect alterations in cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multiparameter FACS assays to detect alterations in cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2984235